MARKETSnap
  • Market Snapshots
    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
    • P/E Ratios
      • Large Caps
      • Absolute
      • Total Market PE
    • Stocks Performance
      • Large Caps
      • Absolute
    • Industries Performance
      • Industry
      • Sector
  • Analyze Stock
    • Analyze a stockAnalyze XRN →
    • FindStock Picks / Stock Screener
    • Value · XRNIntrinsic Value Calculator
    • Invest · XRNInvestment Case
    • Hold · XRN5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding
    Calculator
  • Investing Philosophy
  • More
    • Charts
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
XRN

XRN

Chiron Real Estate Inc.

$30.34
-0.99
 (-3.16%)
Exchange:  NYSE
Market Cap:  401.635M
Shares Outstanding:  2.426M
Delayed data
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Real EstateView sector performance
Industry:  REIT – Healthcare FacilitiesView industry performance
   
CEO:  Mark O. Decker Jr.
Full Time Employees:  30
Address: 
7373 Wisconsin Avenue
Bethesda
MD
20814
US
Website:  https://www.chironre.com
Chiron is a real estate investment trust focused on investing in and actively managing critical healthcare infrastructure. With more than a decade of experience as a public company, it has built a diversified portfolio anchored by strong tenants who deliver essential care in their communities nationwide.

Click to read more…

Revenue Segmentation

🔒 You are currently logged out

Login

It’s free

Industry Peers

TICKERCOMPANYMKT CAPP/EFWD P/EROIC
XRXRN logoXRNChiron Real Estate Inc.401.6M8.610.125.0%
CHCHCT logoCHCTCommunity Healthcare Trust Incorporated379.4M20.336.84.8%
UHUHT logoUHTUniversal Health Realty Income Trust530.2M26.822.1151.8%
STSTRW logoSTRWStrawberry Fields REIT, Inc.182.1M20.217.669.6%
NHNHP logoNHPNational Healthcare Properties, Inc. (…669.0M—29.10.8%
MPMPT logoMPTMedical Properties Trust, Inc.1.8B—75.33.7%

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/05/07 — Q1 quarter 2026

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue140,934138,410161,027
Gross Profit112,852109,15910,323
EBITDA111,63691,46596,732
Operating Income37,86432,67749,367
Net Income20,6126,633-5,836

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets1,267,7011,256,4861,242,465
Total Liabilities661,887700,570712,400
Total Stockholders Equity583,584534,126509,770
Total Debt624,193653,592663,740
Cash and Cash Equivalents1,2786,81512,445

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow68,44070,04673,610
Capital Expenditure-10,046-95,119-81,689
Free Cash Flow58,394-25,073-8,079
Net Income20,6126,633-5,836
Net Change in Cash-7,7312,2182,792

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Low)157,499.605Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (High)190,094.662Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Avg)171,169Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Low)Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (High)Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Avg)Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Low)0Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (High)0Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Avg)0Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Low)20,760.924Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (High)25,057.465Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Avg)22,562.765Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Avg)0Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (High)0Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Low)0Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated Revenue)2Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated EPS)0Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
  ?P/S
 (TTM)
: 
2.84
?Net Income
 (TTM)
: 
  ?P/E
 (TTM)
: 
8.59
?Enterprise Value
 (TTM)
: 
1.071B  ?EV/FCF
 (TTM)
: 
-5.71
?Dividend Yield
 (TTM)
: 
6.37%  ?Payout Ratio
 (TTM)
: 
84.16%
?ROE
 (TTM)
: 
10.77%  ?ROIC
 (TTM)
: 
24.98%
?Net Debt
 (TTM)
: 
  ?Debt/Equity
 (TTM)
: 
0.97
?P/B
 (TTM)
: 
0.68  ?Current Ratio
 (TTM)
: 
20.79

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Research Access for high/low estimates and the interactive table.

Forward P/E 1YResearch AccessResearch AccessResearch AccessResearch Access
10.11Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MarketSnap estimates XRN intrinsic value between $3.84 – $8.45 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate XRN Intrinsic Value

Common questions about XRN valuation

Is Chiron Real Estate Inc. (XRN) overvalued or undervalued right now?

MarketSnap estimates intrinsic value for Chiron Real Estate Inc. (XRN) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is XRN a buy, hold, or sell for long-term investors?

MarketSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether XRN trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is XRN’s P/E ratio?

You can see XRN’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for XRN?

MarketSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MarketSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is XRN a good long-term investment?

Whether XRN fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MarketSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

Research tools for Chiron Real Estate Inc.

  • Chiron Real Estate Inc. intrinsic value calculatorEstimate what the business is worth
  • Chiron Real Estate Inc. 5-year outlookWhat has to go right, and what could go wrong
XRN

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-3.16
MarketSnap

Trading Metrics:

Open: 31.47   Previous Close: 31.33
Day Low: 30.13   Day High: 31.61
Year Low: 29.05   Year High: 38.65
Price Avg 50: 35.7   Price Avg 200: 35.59
Volume: 208652   Average Volume: 103213

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

Global Medical REIT Inc. (NYSE:XRN) Stock Has Average Price Target of $40.17
16-10-2026 02:45
Global Medical REIT Inc. (NYSE:XRN) Stock Has Average Price Target of $40.17
Chiron Real Estate Appoints Charles P. Fitzgerald Chairman of the Board
07-10-2026 16:05
Chiron Real Estate Appoints Charles P. Fitzgerald Chairman of the Board
Chiron Real Estate: A Transformation The Market Still Underestimates
25-08-2026 13:29
Chiron Real Estate: A Transformation The Market Still Underestimates
Global Medical REIT Q2 Earnings Call Highlights
11-08-2026 04:03
Global Medical REIT Q2 Earnings Call Highlights
Chiron Real Estate Inc. (XRN) Q2 2026 Earnings Call Transcript
06-08-2026 13:24
Chiron Real Estate Inc. (XRN) Q2 2026 Earnings Call Transcript
Chiron Real Estate Inc. Accelerates Portfolio Transition via Recapitalization of IRF Assets
30-06-2026 09:22
Chiron Real Estate Inc. Accelerates Portfolio Transition via Recapitalization of IRF Assets

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
      • Large Caps
      • Absolute
      • Total Market PE
      • Large Caps
      • Absolute
      • Industry
      • Sector
    • Analyze a stockAnalyze XRN →
    • FindStock Picks / Stock Screener
    • Value · XRNIntrinsic Value Calculator
    • Invest · XRNInvestment Case
    • Hold · XRN5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding Calculator
    • Charts
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Investing Philosophy
  • Nexus
    • Recent Activity
      • Overview
      • My Valuations
      • My Investment Journal
      • Watchlists & Portfolio
    • Settings
    • Public profile ↗
  • Log in

Media

Watch Listen Read